Szilvia Kiriakov

Szilvia Kiriakov

Auto-generated profile, based on publicly available information

Szilvia Kiriakov

Biological Design Center, Boston University; Program in Molecular Biology, Cell Biology and Biochemistry, Boston University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
BWBrandon G Wong
Brandon G Wong
CMChristopher P Mancuso
Christopher P Mancuso
SKSzilvia Kiriakov
Szilvia Kiriakov
CBCaleb J Bashor
Caleb J Bashor
AKAhmad S Khalil
Ahmad S Khalil

27 August 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZWZohar B. Weinstein
Zohar B. Weinstein
NKNurdan Kuru
Nurdan Kuru
SKSzilvia Kiriakov
Szilvia Kiriakov
APAdam C. Palmer
Adam C. Palmer
AKAhmad S. Khalil
Ahmad S. Khalil
MCMurat Cokol
Murat Cokol
Combination therapies that produce synergistic growth inhibition are widely sought after for the pharmacotherapy of many pathological conditions. Therapeutic selectivity, however, depends on the difference between potency on disease-causing cells and potency on non-target cell types that cause toxic side effects. Here, we examine a model system of antimicrobial compound combinations applied to two highly diverged yeast species. We find that even though the drug interactions correlate between the two species, cell-type-specific differences in drug interactions are common and can dramatically alter the selectivity of compounds when applied in combination vs. single-drug activity—enhancing, diminishing, or inverting therapeutic windows. This study identifies drug combinations with enhanced cell-type-selectivity with a range of interaction types, which we experimentally validate using multiplexed drug-interaction assays for heterogeneous cell cultures. This analysis presents a model framework for evaluating drug combinations with increased efficacy and selectivity against pathogens or tumors.

19 May 2019 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
ZHZachary J. Heins
Zachary J. Heins
CMChristopher P. Mancuso
Christopher P. Mancuso
SKSzilvia Kiriakov
Szilvia Kiriakov
BWBrandon G. Wong
Brandon G. Wong
CBCaleb J. Bashor
Caleb J. Bashor
AKAhmad S. Khalil
Ahmad S. Khalil
Continuous culture methods enable cells to be grown under quantitatively controlled environmental conditions, and are thus broadly useful for measuring fitness phenotypes and improving our understanding of how genotypes are shaped by selection. Extensive recent efforts to develop and apply niche continuous culture devices have revealed the benefits of conducting new forms of cell culture control. This includes defining custom selection pressures and increasing throughput for studies ranging from long-term experimental evolution to genome-wide library selections and synthetic gene circuit characterization. The eVOLVER platform was recently developed to meet this growing demand: a continuous culture platform with a high degree of scalability, flexibility, and automation. eVOLVER provides a single standardizing platform that can be (re)-configured and scaled with minimal effort to perform many different types of high-throughput or multi-dimensional growth selection experiments. Here, a protocol is presented to provide users of the eVOLVER framework a description for configuring the system to conduct a custom, large-scale continuous growth experiment. Specifically, the protocol guides users on how to program the system to multiplex two selection pressures — temperature and osmolarity — across many eVOLVER vials in order to quantify fitness landscapes of Saccharomyces cerevisiae mutants at fine resolution. We show how the device can be configured both programmatically, through its open-source web-based software, and physically, by arranging fluidic and hardware layouts. The process of physically setting up the device, programming the culture routine, monitoring and interacting with the experiment in real-time over the internet, sampling vials for subsequent offline analysis, and post experiment data analysis are detailed. This should serve as a starting point for researchers across diverse disciplines to apply eVOLVER in the design of their own complex and high-throughput cell growth experiments to study and manipulate biological systems.